WO2020044106A2 - Жидкая дозированная форма эдаравона или его фармацевтически приемлемых солей, стабильная при хранении, транспортировании и использовании - Google Patents
Жидкая дозированная форма эдаравона или его фармацевтически приемлемых солей, стабильная при хранении, транспортировании и использовании Download PDFInfo
- Publication number
- WO2020044106A2 WO2020044106A2 PCT/IB2019/000611 IB2019000611W WO2020044106A2 WO 2020044106 A2 WO2020044106 A2 WO 2020044106A2 IB 2019000611 W IB2019000611 W IB 2019000611W WO 2020044106 A2 WO2020044106 A2 WO 2020044106A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- edaravone
- bottle
- lid
- dosage form
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/065—Rigid ampoules, e.g. glass ampoules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1443—Containers with means for dispensing liquid medicaments in a filtered or sterile way, e.g. with bacterial filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2021000603A MX2021000603A (es) | 2018-08-29 | 2019-06-19 | Un metodo de obtencion de la forma de dosis liquida del medicamento edaravone, que es estable durante el almacenamiento, transporte y de uso conveniente. |
BR112021000499-8A BR112021000499A2 (pt) | 2018-08-29 | 2019-06-19 | Método para obter a forma de dosagem líquida do fármaco edaravona, que é estável durante o armazenamento, transporte e conveniente para o uso |
PE2021000068A PE20211209A1 (es) | 2018-08-29 | 2019-06-19 | Un metodo de obtencion de la forma de dosis liquida del medicamento edaravone, que es estable durante el almacenamiento, transporte y de uso conveniente |
US17/265,946 US20210353538A1 (en) | 2018-08-29 | 2019-06-19 | Liquid dosage form of edaravone or pharmaceutically acceptable salts thereof which is stable in storage, transportation and use |
EP19812837.3A EP3831364A2 (en) | 2018-08-29 | 2019-06-19 | Liquid dosage form of edaravone or pharmaceutically acceptable salts thereof which is stable in storage, transportation and use |
EA202190388A EA202190388A1 (ru) | 2018-08-29 | 2019-06-19 | Жидкая дозированная форма эдаравона или его фармацевтически приемлемых солей, стабильная при хранении, транспортировании и использовании |
CN201980057510.3A CN112672733A (zh) | 2018-08-29 | 2019-06-19 | 储存、运输稳定且易用的依达拉奉或药学上可接受的盐的液体剂型 |
CONC2021/0002433A CO2021002433A2 (es) | 2018-08-29 | 2021-02-26 | Un método de obtención de la forma de dosis líquida del medicamento edaravone, que es estable durante el almacenamiento, transporte y de uso conveniente |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201808989 | 2018-08-29 | ||
UAA201808989A UA119731C2 (uk) | 2018-08-29 | 2018-08-29 | Рідка дозована форма едаравону або його фармацевтично прийнятних солей, стабільна при зберіганні, транспортуванні та використанні |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2020044106A2 true WO2020044106A2 (ru) | 2020-03-05 |
WO2020044106A3 WO2020044106A3 (ru) | 2020-04-30 |
Family
ID=68732009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2019/000611 WO2020044106A2 (ru) | 2018-08-29 | 2019-06-19 | Жидкая дозированная форма эдаравона или его фармацевтически приемлемых солей, стабильная при хранении, транспортировании и использовании |
Country Status (12)
Country | Link |
---|---|
US (1) | US20210353538A1 (ru) |
EP (1) | EP3831364A2 (ru) |
CN (1) | CN112672733A (ru) |
BR (1) | BR112021000499A2 (ru) |
CL (1) | CL2021000290A1 (ru) |
CO (1) | CO2021002433A2 (ru) |
EA (1) | EA202190388A1 (ru) |
GE (1) | GEP20237500B (ru) |
MX (1) | MX2021000603A (ru) |
PE (1) | PE20211209A1 (ru) |
UA (1) | UA119731C2 (ru) |
WO (1) | WO2020044106A2 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111615409A (zh) | 2017-11-17 | 2020-09-01 | 科斯卡家族有限公司 | 用于流体输送歧管的系统和方法 |
USD992110S1 (en) | 2021-08-10 | 2023-07-11 | Koska Family Limited | Sealed fluid container |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2262477C (en) * | 1998-05-16 | 2008-02-12 | Bracco International B.V. | Multiple use universal stopper |
US20070166187A1 (en) * | 2006-01-18 | 2007-07-19 | Song Jing F | Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers |
JP5711868B2 (ja) * | 2007-09-28 | 2015-05-07 | テルモ株式会社 | 安定なエダラボン含有水性製剤 |
JP2010077104A (ja) * | 2008-08-29 | 2010-04-08 | Nihon Pharmaceutical Co Ltd | 3−メチル−1−フェニル−2−ピラゾリン−5−オン注射用水溶液 |
JP2011136973A (ja) * | 2009-12-28 | 2011-07-14 | Keiki Imoto | 安定なエダラボン含有水性製剤 |
CN101933899A (zh) * | 2010-08-26 | 2011-01-05 | 南京先声东元制药有限公司 | 一种依达拉奉注射液及其制备方法 |
JP2017202848A (ja) * | 2016-05-11 | 2017-11-16 | 住友ゴム工業株式会社 | 医療用ゴム栓及び医療用ゴム栓の製造方法 |
-
2018
- 2018-08-29 UA UAA201808989A patent/UA119731C2/uk unknown
-
2019
- 2019-06-19 BR BR112021000499-8A patent/BR112021000499A2/pt not_active Application Discontinuation
- 2019-06-19 WO PCT/IB2019/000611 patent/WO2020044106A2/ru unknown
- 2019-06-19 PE PE2021000068A patent/PE20211209A1/es unknown
- 2019-06-19 EA EA202190388A patent/EA202190388A1/ru unknown
- 2019-06-19 GE GEAP201915556A patent/GEP20237500B/en unknown
- 2019-06-19 MX MX2021000603A patent/MX2021000603A/es unknown
- 2019-06-19 CN CN201980057510.3A patent/CN112672733A/zh active Pending
- 2019-06-19 EP EP19812837.3A patent/EP3831364A2/en not_active Withdrawn
- 2019-06-19 US US17/265,946 patent/US20210353538A1/en not_active Abandoned
-
2021
- 2021-02-03 CL CL2021000290A patent/CL2021000290A1/es unknown
- 2021-02-26 CO CONC2021/0002433A patent/CO2021002433A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2021000290A1 (es) | 2021-06-11 |
CO2021002433A2 (es) | 2021-03-19 |
EA202190388A1 (ru) | 2021-06-22 |
UA119731C2 (uk) | 2019-07-25 |
MX2021000603A (es) | 2021-04-13 |
CN112672733A (zh) | 2021-04-16 |
GEP20237500B (en) | 2023-04-25 |
PE20211209A1 (es) | 2021-07-05 |
US20210353538A1 (en) | 2021-11-18 |
EP3831364A2 (en) | 2021-06-09 |
BR112021000499A2 (pt) | 2021-04-06 |
WO2020044106A3 (ru) | 2020-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11166923B2 (en) | Parenteral dosage form of norepinephrine | |
JP5711868B2 (ja) | 安定なエダラボン含有水性製剤 | |
EP3171868B1 (en) | Packaged acetaminophen injection solution preparation | |
JP6869899B2 (ja) | 静脈内注入剤形 | |
WO2020044106A2 (ru) | Жидкая дозированная форма эдаравона или его фармацевтически приемлемых солей, стабильная при хранении, транспортировании и использовании | |
JP2022174188A (ja) | プレフィルドシリンジ用のシリンジ本体 | |
JP2009248983A (ja) | 医薬製剤 | |
JP2011136973A (ja) | 安定なエダラボン含有水性製剤 | |
WO2015147018A1 (ja) | 炎症性自己免疫疾患治療用の注射用水性製剤 | |
JP2014207983A (ja) | アセトアミノフェン注射液製剤 | |
JP7182651B2 (ja) | ビンカアルカロイド薬の投薬形態 | |
UA132698U (uk) | Спосіб пакування стабільної при зберіганні, транспортуванні та зручної при використанні рідкої дозованої форми лікарського засобу - едаравону | |
UA132696U (uk) | Флакон, заповнений рідкою дозованою формою лікарського засобу для парентерального застосування, що містить як активну діючу речовину едаравон або його фармацевтично прийнятні солі | |
UA132697U (uk) | Спосіб одержання стабільної при зберіганні, транспортуванні та зручної при використанні рідкої дозованої форми лікарського засобу едаравону | |
JP6081102B2 (ja) | 安定なグラニセトロン含有水性製剤 | |
JP2024517732A (ja) | 低密度ポリエチレンのコンテナに含まれるデクスメデトミジンの溶液 | |
US20220105000A1 (en) | Stable parenteral dosage form of pyrazolone derivative | |
JP2012001493A (ja) | 塩酸リトドリン注射製剤 | |
UA132695U (uk) | Ампула, заповнена рідкою дозованою формою лікарського засобу для парентерального застосування, що містить як активну діючу речовину едаравон | |
JP2007222270A (ja) | 薬剤包装物 | |
JP2017077484A (ja) | 安定なグラニセトロン含有水性製剤の包装体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112021000499 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 15556 Country of ref document: GE |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2019812837 Country of ref document: EP Effective date: 20210329 |
|
ENP | Entry into the national phase |
Ref document number: 112021000499 Country of ref document: BR Kind code of ref document: A2 Effective date: 20210112 |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19812837 Country of ref document: EP Kind code of ref document: A2 |